Bellerophon Therapeutics, Inc. (BLPH)
OTCMKTS: BLPH · Delayed Price · USD
0.0510
0.00 (0.00%)
Jul 19, 2024, 4:00 PM EDT - Market open
Bellerophon Therapeutics Market Cap
Bellerophon Therapeutics has a market cap or net worth of $623.86 thousand as of July 22, 2024. Its market cap has decreased by -93.63% in one year.
Market Cap
623.86K
Enterprise Value
-3.76M
1-Year Change
-93.63%
Ranking
n/a
Category
Stock Price
$0.05
Market Cap Chart
Since February 13, 2015, Bellerophon Therapeutics's market cap has decreased from $106.80M to $623.86K, a decrease of -99.42%. That is a compound annual growth rate of -44.75%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 13, 2023 | 1.20M | -86.05% |
Dec 30, 2022 | 8.60M | -70.85% |
Dec 31, 2021 | 29.50M | -53.47% |
Dec 31, 2020 | 63.40M | 163.07% |
Dec 31, 2019 | 24.10M | -48.72% |
Dec 31, 2018 | 47.00M | -66.99% |
Dec 29, 2017 | 142.40M | 1,798.67% |
Dec 30, 2016 | 7.50M | -80.67% |
Dec 31, 2015 | 38.80M | -63.67% |
Feb 13, 2015 | 106.80M | - |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly | 814.94B |
Novo Nordisk | 579.91B |
UnitedHealth Group | 520.32B |
Johnson & Johnson | 372.29B |
Merck & Co. | 318.55B |
AbbVie | 304.29B |
AstraZeneca | 244.04B |
Novartis AG | 207.64B |